The 2 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +386.18% increase from the last price of 0.72.
The current consensus among 3 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.41
Reporting Date Aug 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.